ETHAPE: Identification of Criteria of the Success of the Endarterectomy in Chronic Pulmonary Post Embolic Hypertension

Sponsor
Assistance Publique - Hôpitaux de Paris (Other)
Overall Status
Completed
CT.gov ID
NCT00657722
Collaborator
(none)
249
2
1
46
124.5
2.7

Study Details

Study Description

Brief Summary

In order to improve effectiveness of the surgical operation thanks to a reduction in the rate of failure, this study will allow us to identify predictive angiographic and CT finding of surgical failure, starting from standardized reading grids, in order to have a better selection of the operable patients.

Condition or Disease Intervention/Treatment Phase
  • Other: Angiography and Computed Tomography
N/A

Detailed Description

Chronic thromboembolic pulmonary hypertension(CTEPH) is caused by obstruction of the large pulmonary arteries by acute and recurrent pulmonary emboli, and organization of these blood clots. ANTOINE BECLERE respiratory unit, in partnership with the MARIE LANNELONGUE hospital thoracic and vascular surgery departments was designated recently as reference national centre for pulmonary hypertension and represents the only French structure for evaluation of CTEPH with 150 patients addressed each year.If the disease is proximately located, CTEPH can be cured surgically through a complex surgical procedure performed under Hypothermia and total circulatory arrest. In spite of multidisciplinary meeting deciding the operability of each case the rate of failure is approximately of 15% (9% of operative mortality rate and 6% of technical failure).

The aim of this study is to identify predictive angiographic and CT findings of success, by allowing a better selection of operable patients.

It would be possible to improve the effectiveness of the surgical treatment and reduce the rate failure from 15% to 7 % or even 5 %.

Study Design

Study Type:
Interventional
Actual Enrollment :
249 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Diagnostic
Official Title:
Identification Of The Predictive Angiographic And Computed Tomographic (CT) Criteria Of The Success Of The Thromboendarterectomy In Chronic Pulmonary Hypertension
Study Start Date :
Jan 1, 2008
Actual Primary Completion Date :
Jul 1, 2011
Actual Study Completion Date :
Nov 1, 2011

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1

Angiography and Computed Tomography

Other: Angiography and Computed Tomography
Preoperative angiography and Computed Tomography
Other Names:
  • standardized reading grids of APN and ASMD
  • Outcome Measures

    Primary Outcome Measures

    1. surgical effectiveness evaluated by the death or failure rate. [6 months]

    Secondary Outcome Measures

    1. surgical effectiveness evaluated by the death or failure rate. [3 months]

    2. Check that none of the patients considered unresectable on data from staff was declared operable with the criteria predictive success of imaging examinations. [before surgery]

    3. Determine the interest of pulmonary angiography in the operability decision compared first to Multi detector AngioCT alone with standardized analyze and then with the both exams. [before surgery]

    4. Determine the incidence of adverse events associated with each of these two exams or their combination. [3 and 6 months after surgery]

    5. Check-inter-observer reproducibility of standardized reading grids of pulmonary angiography and MD-AngioCT [Before surgery]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients addressed to the reference centre of pulmonary hypertension for a suspected CPC-PE

    • Achieving an assessment prior to the operation, including:1) Right cardiac catheterization confirming HTP with a mean pulmonary arterial pressure> 25 mm Hg at rest; 2) Echography and Doppler of the lower limbs in search of phlebitis sequela; 3) Pulmonary scintigraphy with 6 views in ventilation and perfusion; 4) Digital pulmonary angiography; 5) A 64 detector pulmonary computed tomography; 6) Having read the briefing note and given their agreement.

    Exclusion criteria:
    • Refusal examinations .

    • Patient for which one method is contraindicated

    • Patient considered not operable by the staff

    • Life expectancy of less than 3 months

    • Geographical distance for the clinical follow-up at 3 months

    • Renal insufficiency (creatinine clearance <30 mL / min)

    • Proven allergy to iodinated contrast agents

    • Pregnant woman.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hôpital Antoine Beclere Clamart France 92141
    2 Hospital Marie Lannelongue Le Plessis Robinson France 92350

    Sponsors and Collaborators

    • Assistance Publique - Hôpitaux de Paris

    Investigators

    • Principal Investigator: Mathieu LIBERATORE, MD, Assistance Publique - Hôpitaux de Paris Hôpital Antoine Béclère
    • Study Director: Dominique MUSSET, MD, PhD, Assistance Publique - Hôpitaux de Paris, Hôpital Antoine Béclère
    • Study Director: Gerald SIMONNEAU, MD, PhD, Assistance Publique - Hôpitaux de Paris, Hôpital Antoine Béclère

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Assistance Publique - Hôpitaux de Paris
    ClinicalTrials.gov Identifier:
    NCT00657722
    Other Study ID Numbers:
    • K060205
    First Posted:
    Apr 14, 2008
    Last Update Posted:
    Apr 11, 2013
    Last Verified:
    Apr 1, 2013

    Study Results

    No Results Posted as of Apr 11, 2013